ABNORMAL TCR V-BETA REPERTOIRE IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA

被引:20
作者
COLEMAN, S [1 ]
PERERA, P [1 ]
FISHER, J [1 ]
HOY, T [1 ]
BURNETT, AK [1 ]
LIM, SH [1 ]
机构
[1] UNIV WALES COLL MED,DEPT HAEMATOL,CARDIFF CF4 4XN,S GLAM,WALES
关键词
CML; TCR V-BETA REPERTOIRE; DELETION;
D O I
10.1111/j.1365-2141.1995.tb05159.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have used 25 sets of oligonucleotide primers specific for the 24 known major human T-cell receptor (TCR) V beta families in polymerase chain reactions to analyse the T-cell repertoire of the peripheral blood in seven patients with chronic myeloid leukaemia (CML). In contrast to normal healthy individuals, all seven patients exhibited variable degrees of TCR V beta specific T-cell,deletion, ranging from two to eight of the 24 major families. T cells bearing V beta 17 and 8 were most commonly deleted. These results suggest a superantigen effect associated with CML, The patterns of deletion did not appear to correlate with either of the two bcr-abl transcripts. The reason and aetiological agent responsible for the T-cell deletion remain speculative. Further work is ongoing to characterize this phenomenon in animal models and patients with CML.
引用
收藏
页码:358 / 363
页数:6
相关论文
共 22 条
  • [1] CAIGNARD A, 1994, CANCER RES, V54, P1292
  • [2] INTERACTION OF STAPHYLOCOCCUS-AUREUS TOXIN SUPERANTIGENS WITH HUMAN T-CELLS
    CHOI, YW
    KOTZIN, B
    HERRON, L
    CALLAHAN, J
    MARRACK, P
    KAPPLER, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8941 - 8945
  • [3] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [4] T-CELL ANTIGEN RECEPTOR GENES AND T-CELL RECOGNITION
    DAVIS, MM
    BJORKMAN, PJ
    [J]. NATURE, 1988, 334 (6181) : 395 - 402
  • [5] GENERATION OF LEUKEMIA-REACTIVE CYTOTOXIC LYMPHOCYTE-T CLONES FROM THE HLA-IDENTICAL BONE-MARROW DONOR OF A PATIENT WITH LEUKEMIA
    FABER, LM
    VANLUXEMBURGHEIJS, SAP
    WILLEMZE, R
    FALKENBURG, JHF
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1283 - 1289
  • [6] FERRADINI L, 1992, CANCER RES, V52, P4649
  • [7] HALE G, 1994, BONE MARROW TRANSPL, V13, P597
  • [8] T-CELL TOLERANCE BY CLONAL ELIMINATION IN THE THYMUS
    KAPPLER, JW
    ROEHM, N
    MARRACK, P
    [J]. CELL, 1987, 49 (02) : 273 - 280
  • [9] DONOR LEUKOCYTE TRANSFUSIONS FOR TREATMENT OF RECURRENT CHRONIC MYELOGENOUS LEUKEMIA IN MARROW TRANSPLANT PATIENTS
    KOLB, HJ
    MITTERMULLER, J
    CLEMM, C
    HOLLER, E
    LEDDEROSE, G
    BREHM, G
    HEIM, M
    WILMANNS, W
    [J]. BLOOD, 1990, 76 (12) : 2462 - 2465
  • [10] RECURRENCE OF PH'-POSITIVE LEUKEMIA IN DONOR CELLS AFTER MARROW TRANSPLANTATION FOR CHRONIC GRANULOCYTIC-LEUKEMIA
    MARMONT, A
    FRASSONI, F
    BACIGALUPO, A
    PODESTA, M
    PIAGGIO, G
    VANLINT, MT
    CAIMO, A
    DEFILIPPI, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (14) : 903 - 906